Clinical Trial Update: Randomized Study on Efficacy of Gemifloxacin-based Regimen for Helicobacter Pylori Infection [Phase 3]

View source ↗

Summary

A randomized Phase 3 study is evaluating a gemifloxacin-based regimen for Helicobacter pylori infection; the current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Gemifloxacin (gemifloxacin)

Snippet

Sponsor: Samsung Medical Center | Conditions: Helicobacter Pylori Infection | Phase 3 | Status: UNKNOWN